| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/18/2011 | US7871784 mucins (MUC1); drug screening; gene expression inhibition; competitive binding; for treatment of cancer and inflammation |
| 01/18/2011 | US7871783 Immunostaining; hydrogen bonding; proteolysis |
| 01/18/2011 | US7871782 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy |
| 01/18/2011 | US7871781 Two step lateral flow assay methods and devices |
| 01/18/2011 | US7871775 Compositions and methods for the identification, assessment, prevention and therapy of human cancers |
| 01/18/2011 | US7871773 Aza-benzazolium containing cyanine dyes |
| 01/18/2011 | US7871772 Clearing misfolded proteins from blood via incubation with proteon nucleation center (PNC) which comprise metallic nanoparticles consisting of copper, zinc and/or iron; diagnosing metabolic disorders |
| 01/18/2011 | US7871769 Using variation in tumor marker expression as diagnostic/prognostic indicator of antitumor agent efficacy; gene expression profiling and metastasis |
| 01/18/2011 | US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications |
| 01/18/2011 | US7871763 gene expression; probes, primers, antibodies |
| 01/18/2011 | US7871762 Hyperglycosylated hCG (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease |
| 01/18/2011 | US7871619 Using orphan receptors expressed on cell surfaces as screening tool in identifying modulating agents of cell proliferation; antitumor agents |
| 01/18/2011 | US7871615 Humanized antibodies that recognize beta amyloid peptide |
| 01/18/2011 | US7871614 Gold-binding protein and use thereof |
| 01/18/2011 | US7871610 Antibodies to Tie1 ectodomain |
| 01/18/2011 | US7871573 Enhancing fluorescent signal of labeled immunoglobulin via surrounding fluorophore with nanometal particle in self-assembled monolayer; sandwich immunoassay |
| 01/18/2011 | US7871572 Chemical sensors based on metal nanoparticle encapsulated by mixed ligand and sensor array |
| 01/18/2011 | US7871571 utilizes a pair of ciliated sensors to produce a three-dimensional image of a biomolecule under study |
| 01/18/2011 | US7871569 apparatus comprising functionalized piezoelectric resonator for use in monitoring glucose, potassium, calcium and/or carbon dioxide concentrations in blood samples |
| 01/18/2011 | US7871568 test assemblies that may be used for rapid testing of solid, semi-solid, or liquid specimens; for testing the presence of fecal occult blood, urine, saliva |
| 01/18/2011 | US7871385 Urine sample collection device |
| 01/18/2011 | CA2567856C Use of a dialysis membrane for reducing blood free light chain concentration |
| 01/18/2011 | CA2511128C Late-pcr |
| 01/18/2011 | CA2499397C Fluid condition monitor |
| 01/18/2011 | CA2479045C Amplification-hybridisation method for detecting and typing human papillomavirus |
| 01/18/2011 | CA2455145C Pregnancy-related serine protease |
| 01/18/2011 | CA2447696C Fxiii detection for verifying serum sample and sample size and for detecting dilution |
| 01/18/2011 | CA2440242C Method and apparatus for on-line monitoring of quality and/or condition of highly resistive fluids |
| 01/18/2011 | CA2385482C A substrate and a method for determining and/or monitoring electrophysiological properties of ion channels |
| 01/18/2011 | CA2383737C Muc-1 derived peptides |
| 01/18/2011 | CA2189055C Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 01/18/2011 | CA2156976C Genetic sequences encoding glucocorticoid dehydrogenases and uses therefor |
| 01/14/2011 | CA2709544A1 Methods for utilizing hltf activity |
| 01/14/2011 | CA2709192A1 Diagnostic test strip having fluid transport features |
| 01/14/2011 | CA2708845A1 Blood glucose sensor |
| 01/13/2011 | WO2011006145A2 Compositions and methods for mammalian genetics and uses thereof |
| 01/13/2011 | WO2011006118A2 Custom filtration slide and filtration apparatus and method |
| 01/13/2011 | WO2011006021A1 Apparatus and method for barcoded magnetic beads analysis |
| 01/13/2011 | WO2011006011A2 Theranostic polycation beacons comprising oligoethyleneamine repeating units and lanthanide chelates |
| 01/13/2011 | WO2011005982A1 Bacterial adherence and anti-adherence to mucus, epithelial cells and other cells |
| 01/13/2011 | WO2011005893A2 Biomarkers and methods for detecting alzheimer's disease |
| 01/13/2011 | WO2011005882A2 Cascaded gas chromatographs (cgcs) with individual temperature control and gas analysis systems using same |
| 01/13/2011 | WO2011005818A1 Purification of monoclonal antibodies |
| 01/13/2011 | WO2011005628A1 Detection of neurodegenerative disease |
| 01/13/2011 | WO2011005587A1 Vaccine compositions and methods of use to protect against infectious disease |
| 01/13/2011 | WO2011005570A2 Systems and methods for treating, diagnosing and predicting the response to therapy of breast cancer |
| 01/13/2011 | WO2011005504A1 Methods for predicting a cancer patient's response to antifolate therapy |
| 01/13/2011 | WO2011005496A2 Islet1 (isl1) and hearing loss |
| 01/13/2011 | WO2011005357A2 Immunogenicity assay |
| 01/13/2011 | WO2011005289A2 Methods and kits for measuring enzyme activity |
| 01/13/2011 | WO2011005221A1 Methods of identifying a pair of binding partners |
| 01/13/2011 | WO2011005110A1 Method and apparatus for inspection of surfaces |
| 01/13/2011 | WO2011005094A1 High throughput method and system for in vivo screening |
| 01/13/2011 | WO2011004949A1 Screening method of therapeutic and diagnostic agents for tnf-alpha-induced diseases using reactive oxygen species modulator 1 |
| 01/13/2011 | WO2011004899A1 Cancerous disease modifying antibodies |
| 01/13/2011 | WO2011004430A1 Method for extracting hexavalent chromium |
| 01/13/2011 | WO2011004324A1 Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections |
| 01/13/2011 | WO2011004308A1 Surface coating for laser desorption ionization mass spectrometry of molecules |
| 01/13/2011 | WO2011004197A1 Screening method for cell aging |
| 01/13/2011 | WO2011004158A1 Solubilisation of membrane proteins |
| 01/13/2011 | WO2011004148A1 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis |
| 01/13/2011 | WO2011004136A1 Graphene biosensor |
| 01/13/2011 | WO2011004015A2 Management of a number of swimming pools |
| 01/13/2011 | WO2011004009A1 Use of creatinine as dilution agent to determine the bodily composition of a mammal |
| 01/13/2011 | WO2011003984A1 Means and methods for detecting and identifying a novel bacterium responsible for phytosanitary disorders in plants (zucchini) and novel resistant plants |
| 01/13/2011 | WO2011003945A1 Methods for analyzing polar metabolites of the energy metabolism |
| 01/13/2011 | WO2011003941A1 Device for detection of biological agents |
| 01/13/2011 | WO2011003923A1 Device for measuring at least one property of water |
| 01/13/2011 | WO2011003922A1 Method for the diagnosis of asthma by detecting volatile organic compounds in exhaled air |
| 01/13/2011 | WO2011003905A1 Biomarker for selecting patients and related methods |
| 01/13/2011 | WO2011003896A1 Detection and visualization of the cell cycle in living cells |
| 01/13/2011 | WO2011003885A1 Method for predicting disease free survival in patients with ovarian cancer |
| 01/13/2011 | WO2011003883A1 Process for the identification of compounds for treating cancer |
| 01/13/2011 | WO2011003868A1 System and method for testing devices using powders |
| 01/13/2011 | WO2011003809A1 Role of pld1 in thrombus formation and integrin alpha iib beta 3 activation |
| 01/13/2011 | WO2011003654A1 Arrangement, substrate and method for preparing a cell sample |
| 01/13/2011 | WO2011003623A2 Method and marker for the individual prognosis and/or the individual detection of neuropathy |
| 01/13/2011 | WO2011003598A2 Detection of antigens |
| 01/13/2011 | WO2011003586A1 Chip for determination of molecular structures and functions |
| 01/13/2011 | WO2011003583A1 Sensor as biochip |
| 01/13/2011 | WO2011003424A1 Nucleic acid nano-biosensors |
| 01/13/2011 | WO2011003369A1 New tumor marker |
| 01/13/2011 | WO2011003281A1 Device and method for analyzing analyte in liquid sample |
| 01/13/2011 | WO2011003193A1 Compounds and methods for detection and quantification of carboxylic acids |
| 01/13/2011 | WO2011003182A1 Methods for early detection of blood disorders |
| 01/13/2011 | WO2010138839A9 Use of 2 anti-sparc antibodies to predict response to chemotherapy |
| 01/13/2011 | WO2010138456A3 B cell signature associated with tolerance in transplant recipients |
| 01/13/2011 | WO2010135411A3 Aurora-a copy number and sensitivity to inhibitors |
| 01/13/2011 | WO2010133963A3 Forming sample combinations using liquid bridge systems |
| 01/13/2011 | WO2010129515A8 Modulation of the tgf-beta and pi3k/akt pathways in the diagnosis and treatment of squamous cell carcinoma |
| 01/13/2011 | WO2010127045A3 Method and system for calling variations in a sample polynucleotide sequence with respect to a reference polynucleotide sequence |
| 01/13/2011 | WO2010121223A3 Electromagnetic molecular sensors and methods of using same |
| 01/13/2011 | WO2010120917A3 Expanding the dynamic range of a test strip |
| 01/13/2011 | WO2010118288A3 Method and apparatus for forming a homeostatic loop employing an aptamer biosensor |
| 01/13/2011 | WO2010118185A3 Hand-held scanner systems and methods for reading point of care test results |
| 01/13/2011 | WO2010118035A3 Biomarkers for monitoring treatment of neuropsychiatric diseases |
| 01/13/2011 | WO2010117609A3 Prosthetic heart valve system with positoning markers |
| 01/13/2011 | WO2010115749A3 Fibrosis biomarker assay |
| 01/13/2011 | WO2010115147A3 Biomolecular sensing with metal-nanostructures |
| 01/13/2011 | WO2010114686A3 Modulation of abcg2-mediated urate transport to treat hyperuricemia and gout |